Biomea Fusion, Inc. Public Float
Biomea Fusion, Inc. (BMEA) had Public Float of $93.61 million as of 2025-06-30, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-24
- 2025-06-30: Entity Public Float $93.61M.
- 2024-06-30: Entity Public Float $124.15M.
- 2023-06-30: Entity Public Float $596.91M.
- 2022-06-30: Entity Public Float $255.91M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $93.61M 10-K · filed 2026-03-24 |
| 2024-06-30 | $124.15M 10-K · filed 2025-03-31 |
| 2023-06-30 | $596.91M 10-K · filed 2024-03-28 |
| 2022-06-30 | $255.91M 10-K · filed 2023-03-28 |
| 2021-06-30 | $235.62M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |